Showing 901-910 of 4169 results for "".
Future Forward: Next-Gen Injectable Combinations
https://beta.modernaesthetics.com/conferences/tell-all-tribune/future-forward-next-gen-injectable-combinations/33783/Jennifer Pearlman, MD, CCFP, NCMP, FAARM, ABAARM, discusses the future of regenerative aesthetics and the tools available to help patients age well at the 2024 Tell-All Tribune: An Aesthetic Think Tank. She emphasizes that aging is not inevitable and that proactive measures can be taken to support lBeyond Branding: Community Before the Brand
https://beta.modernaesthetics.com/series/revision-skincare/beyond-branding-community-before-the-brand/33739/Learn how experts authentically connect with consumers and patients to turn their communities into a thriving brand. Drew Fine, CEO - Dfine Group Jordan Harper, FNP-C/Owner* - Barefaced Steffanie Attenberg, Chief Brand & Content Officer - NewBeautyBuilding a Company Through Culture: A CEO Perspective
https://beta.modernaesthetics.com/series/revision-skincare/building-a-company-through-culture-a-ceo-perspective/33738/Five diverse CEOs talk about how company culture is at the nucleus of every successful business. This session explores how these CEOs prioritize shared values, behaviors, and standards to scale and remain agile in a competitive market. Maria Carell, CEO/President - Revision Skincare® Ethan Min, GloDoes an IV Hydration Therapy Practice Need a Medical Director?
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/does-an-iv-hydration-therapy-practice-need-a-medical-director/35231/It’s important to understand requirements in your state.MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://beta.modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA PhaseThe Next Big Thing
https://modernaesthetics.com/topics/practice-development/the-next-big-thing/35174/Will Nextdoor become the next big social network?The ACTS Program: Adding Testing to Your Defense Against COVID-19
https://modernaesthetics.com/ma-supplements/2020-nov-dec-supplement3/the-acts-program-adding-testing-to-your-defense-against-covid-19-1/34991/Adopting a simple testing and safety platform for personal protective equipment and sterilization protocols adds a layer of protection for patients and office staff.Outsourced COOs: The Next Big Thing?
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/outsourced-coos-the-next-big-thing/34973/A new service to support practice growth is blossoming in the heartland. The founders discuss the concept.Virtual Voice: Three Medaesthetics Myths We Need to Bust
https://modernaesthetics.com/ma-issues-index/2018-sept-oct/three-medaesthetics-myths-we-need-to-bust/34080/A recent RealSelf Aesthetics Interest Survey reveals eye-opening trends.The Millennials are Coming
https://modernaesthetics.com/ma-issues-index/2016-jan-feb/the-millennials-are-coming/34440/The new generation learns, interacts, and is inspired differently than a generation ago, and to stay relevant it is necessary to adapt.